María Sereno

Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

María Apellániz-Ruiz, Miyoung Lee, Lara M. Munín Sánchez et al. · Clinical Cancer Research · 2014 · 72 citations · Full text

CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response

J. Bargiela-Iparraguirre, L Prado-Marchal, Marta Fernández-Fuente et al. · Scientific Reports · 2016 · 51 citations · Full text

Transcriptional Regulation, Chk1 Expression, Oncology +14

Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer

Lara P. Fernández, Maria J. Merino, Gonzalo Colmenarejo et al. · Molecular Oncology · 2020 · 51 citations · Full text

Statins Treatment, Lipid Peroxidation, Anticancer Effectiveness +19

A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation

María Sereno, Víctor Moreno, Juan Moreno‐Rubio et al. · Anti-Cancer Drugs · 2015 · 36 citations

Significant Response, Somatic Variant, Oncogenic Agent +15

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

Lara M. Munín Sánchez, María Apellániz-Ruiz, Gerardo Gutiérrez‐Gutiérrez et al. · The Oncologist · 2018 · 36 citations · Full text